The present invention relates to the use of an NK-1 receptor antagonist and a selective serotonin reuptake inhibitor for the treatment or prevention of obesity....http://www.google.com.au/patents/US6162805?utm_source=gb-gplus-sharePatent US6162805 - Use of an NK-1 receptor antagonist and an SSRI for treating obesity
